Product Information
OTEZLA 10-20-30 MG START 28 DAY is a brand product labeled by Amgen Inc., priced at $98.5508 per EA under NDC 55513036955. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Mar 21, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Amgen Inc.NDC
55513036955
Classification
Brand
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
New Drug (NDA)
FDA Application
NDA205437FDA Approved
3/21/2014
TE Code
AB
On Market Since
2/26/2020
Price Statistics
The NADAC for OTEZLA 10-20-30 MG START 28 DAY has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 15.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $98.5508 per EA |
|---|---|
| All-time high | $98.8902 (Jun 10, 2026) |
| All-time low | $85.1942 (Apr 17, 2024) |
| 52-week high | $98.8902 |
| 52-week low | $94.1811 |
| Median price | $94.1811 |
| Average price | $93.1576 |
| Largest weekly change | +7.0% (Jan 15, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the apremilast market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OTEZLA 10-20-30 MG START 28 DAY?
The current National Average Drug Acquisition Cost (NADAC) for OTEZLA 10-20-30 MG START 28 DAY, manufactured by Amgen Inc., is $98.5508 per EA (NDC 55513036955), effective Aug 19, 2026.
How has the price of OTEZLA 10-20-30 MG START 28 DAY changed over time?
Over the history we have for it, the NADAC for OTEZLA 10-20-30 MG START 28 DAY has risen 15.7%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for OTEZLA 10-20-30 MG START 28 DAY?
Since Apr 17, 2024, the NADAC for OTEZLA 10-20-30 MG START 28 DAY has ranged from a low of $85.1942 (Apr 17, 2024) to a high of $98.8902 (Jun 10, 2026), with a median of $94.1811 per EA.
Are there cheaper alternatives to OTEZLA 10-20-30 MG START 28 DAY?
No other NADAC-published product currently shares the active ingredient and strength of OTEZLA 10-20-30 MG START 28 DAY in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OTEZLA 10-20-30 MG START 28 DAY?
OTEZLA 10-20-30 MG START 28 DAY (NDC 55513036955) is labeled by Amgen Inc., and CMS classifies it as a brand product.